Company / Revenue per Share
AIM ImmunoTech Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.13
FY2025
5-year range
$0.00 / $0.13
FY2021-FY2025
Trend
+3164.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +3165% YoY in FY2025, a notable deviation from the 9-year average annual change of +464%.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of +53.6%.
Improved from $0.00 to $0.13 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +262.8%
- 5-Year CAGR
- +53.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 3164.5% year-over-year.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | +3164.5% |
| FY2024 | $0.00 | +40.3% |
| FY2023 | $0.00 | +4.2% |
| FY2022 | $0.00 | -27.3% |
| FY2021 | $0.00 | -75.4% |
| FY2020 | $0.02 | -87.6% |
| FY2019 | $0.13 | +1032.6% |
| FY2018 | $0.01 | +103.1% |
| FY2017 | $0.01 | +23.2% |
| FY2016 | $0.00 | +584.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026